Quant Biomarkers

Quant Biomarkers

Biotechnologieforschung

Quant Biomarkers is a data-driven biomedical and longevitytech company.

Info

Quant Biomarkers is a data-driven biomedical company focused on analysis and validation of longitudinal clinical data and personalised biomarkers assessment to support intervention decisions and Longevity Medicine therapeutic modalities. By applying rapidly advanced biological science and technolgy for infomed clinical decisions we drive effective clinical care.

Branche
Biotechnologieforschung
Größe
2–10 Beschäftigte
Hauptsitz
Basel
Art
Privatunternehmen

Orte

Beschäftigte von Quant Biomarkers

Updates

  • Unternehmensseite von Quant Biomarkers  anzeigen, Grafik

    317 Follower:innen

    Profil von Dr. Sanja Tomovska anzeigen, Grafik

    Entrepreneur I CEO Quant Biomarkers I Board member | Healthy Longevity I Transforming Healthcare with new wave technologies I Strategic Alliances I INSEAD

    Celebrating Women's Longevity🥀 🌺🌻#internationalwomensday2024 The remarkable contributions of women extend far beyond just one day on March 8; there are countless examples throughout the year. I had several unique moments where I have been deeply moved by remarkable women leaders driving for change and progress in sustainable healthcare for everyone. #sustainablehealth. I am honored to have met amazing and accomplished women on the Humansa #International #advisoryboard in Hong Kong. The purpose is significant 💫 : Reimagine health to ensure that no one misses out on the opportunity for a fulfilling and happy life. Humansa owns a network of 40 Health and Wellness Centers throughout the Greater Bay Area. The impact is deep, urging all of us, men and women alike, to prioritize our health as the most precious gift we have. Let's join hands 👐 for health and longevity, wishing everyone great success. Denise Lo Catherine YuElaine JiangAngel ChiaWONG Wan Shan, Samantha @Denise Lo Fung  #advisoryboards#ongevity clinics#humansa Don So

    • HUMANSA ADVISORY BOARD
    • HUMANSA WINING TEAM
    • HUMANSA HOME
    • NEW HEAlTH IS OUR WEALTH
  • Unternehmensseite von Quant Biomarkers  anzeigen, Grafik

    317 Follower:innen

    🚀 Exciting Collaboration & preparation of out-licensing: Xlife Sciences AG & Quant Biomarkers AG We're excited to announce a groundbreaking collaboration between Xlife Sciences AG and Quant Biomarkers AG, a strategic move that not only advances CKD diagnosis but also paves the way for our next successful out-licensing venture. 🔬 Revolutionizing CKD Detection - This partnership focuses on developing innovative biomarkers for early detection of chronic kidney disease (CKD), a condition affecting 13.4% of the global population. Our collaboration is set to transform the approach to CKD diagnosis, offering hope for earlier and more effective treatment. 💡 Vision for the Future - Our goal is to change the landscape of CKD treatment, allowing for early intervention and potentially preventing irreversible kidney damage. 🚀 A Step Towards Transformative Healthcare - Join us on this exciting journey as we redefine kidney health and set new standards in the life sciences sector. https://lnkd.in/edB8HMnd

    • Kein Alt-Text für dieses Bild vorhanden

Ähnliche Seiten